文献速递前列腺增生与排尿功能障碍泌尿系感染

新冠感染对BPH患者血清PSA水平的影响:前瞻性队列研究

Variation of Serum PSA Levels in COVID-19 Infected Male Patients with Benign Prostatic Hyperplasia (BPH): A Prospective Cohort Studys.
PubMed 文献 · Urology · 2021-10-06

本研究回顾性分析了91例BPH男性患者在三时间点的血清总PSA水平,发现新冠急性感染期PSA显著高于感染前和康复后,提示急性期及治疗后早期测量PSA可能造成误导性评估。

要点

  • 新冠急性感染期PSA显著升高,感染前为1.58±1.09 ng/mL,感染期为4.34±3.78 ng/mL,康复后为2.09±2.70 ng/mL。
  • 感染期PSA与感染前及康复后比较均有统计学显著差异(P<.001)。
  • BPH患者急性感染期及治疗后早期测PSA可能误导前列腺疾病诊疗决策。

核心结论

  • SARS-CoV-2感染导致BPH男性患者在急性感染期血清总PSA水平显著升高。

研究设计与样本

  • 前瞻性队列研究,纳入91例既往3至6个月内测过PSA且确诊新冠的BPH男性患者。
  • 在新冠确诊首日及治疗结束后第三个月复查PSA,比较感染前、感染期和康复后三个时间点的PSA水平。

主要发现

  • 感染前PSA为1.58±1.09 ng/mL,感染期为4.34±3.78 ng/mL,康复后为2.09±2.70 ng/mL。
  • 感染期PSA显著高于感染前(P<.001)和康复后(P<.001)。

临床怎么用

  • BPH患者急性新冠感染期及治疗后早期测量PSA可能造成假性升高,应避免据此进行前列腺疾病的诊断或调整治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the effect of SARS CoV-2 on serum total PSA levels in men with BPH diagnosed with COVID-19. METHODS: The PSA (Kit: Immunoassay Program- Cycle 18, Siemens Atellica IM Analyzer) levels in patients who had had a PSA check at least 3 months, but no more than 6 months, prior to diagnosis of acute COVID-19 infection, were examined retrospectively. PSA levels were measured and recorded from these patients on the first day of diagnosis of COVID-19. These patients were called back for urology outpatient follow-up at the third month after the end of the COVID-19 treatment. PSA levels measured in the pre-COVID-19 period, during the period of active infection with COVID-19, and in the post-COVID-19 period were compared. RESULTS: In total, 91 patients had a serum PSA level of 1.58 ± 1.09 ng/mL in the pre-COVID-19 period, a serum PSA level of 4.34 ± 3.78 ng/mL measured in the COVID-19 period and 2.09 ± 2.70 ng/mL in the post-COVID-19 period. It was determined that the serum PSA level measured during active COVID-19 infection was statistically significantly higher than the PSA levels measured according to the pre-COVID-19 period and the post-COVID-19 period (P < .001, P < .001; respectively). CONCLUSION: SARS-CoV-2 infection in men diagnosed with BPH causes significant increases in PSA levels during the active period of the disease. Measurement of PSA values used in the diagnosis, differential diagnosis, and follow-up of prostate diseases in the acute period of infection and in the early period after infection treatment may cause false evaluations that may affect the diagnosis and treatment steps of prostate diseases in these patients.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Cinislioglu AE, Demirdogen SO, Cinislioglu N, et al. Variation of Serum PSA Levels in COVID-19 Infected Male Patients with Benign Prostatic Hyperplasia (BPH): A Prospective Cohort Studys. Urology. 2021. PMID: 34626600. doi:10.1016/j.urology.2021.09.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。